Shares of drug firm Granules India
today surged over 6 per cent after the company said it has
received Establishment Inspection Report (EIR) from the US
health regulator for the OmniChem facility at Vizag, Andhra
The stock soared 6.37 per cent to end at Rs 121.85 on
BSE. During the day, it jumped 7.20 per cent to Rs 122.80.
At NSE, shares of the company rose by 6.19 per cent to
settle at Rs 121.80.
The company's market valuation went up by Rs 472.16 crore
to Rs 3,092.16 crore.
In terms of equity volume, 8.12 lakh shares of the
company were traded on BSE and over 98 lakh shares changed
hands at NSE during the day.
OmniChem facility is operated by 50:50 joint venture of
Granules India and Ajinimoto OmniChem N V, it said in a filing
"This facility was inspected by the USFDA in December
2016 and there were seven observations during the inspection.
The facility manufactures Active Pharmaceutical Ingredients
(API) intermediates," Granules India said.
(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)